Cargando…
Use of Heart Failure-Exacerbating Medications among Heart Failure Patients in a Tertiary Referral Centre in Malaysia
Autor principal: | Wong, Yii Ching |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Radcliffe Cardiology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10316340/ https://www.ncbi.nlm.nih.gov/pubmed/37405338 http://dx.doi.org/10.15420/ecr.2023.18.PO20 |
Ejemplares similares
-
Evaluation of β-blocker Dose Optimisation Among Patients Attending Heart Failure Clinic at Sarawak Heart Centre, Malaysia
por: Wong, Yii Ching, et al.
Publicado: (2021) -
Role of Water-soluble Vitamins in Reducing the Risk of Cardiovascular Heart Disease in Premature Ovarian Insufficiency Patients
por: Patil, Rushikesh Rajesh
Publicado: (2023) -
Oral Presentation Award Winner: The Predictive Value of NT-proBNP across Glomerular Filtration Rate Subsets in Heart Failure Treated Patients
por: Ionescu, Diana, et al.
Publicado: (2023) -
HDL Mimetics Enhances Mitochondrial Function via Stimulation of PGC1-α
por: Zhang, Hang, et al.
Publicado: (2023) -
Evolocumab is initiated in Central and Eastern Europe at Much Higher LDL-C Levels than Recommended in Guidelines: Results from the Observational HEYMANS Study
por: Blaha, V, et al.
Publicado: (2023)